Amdocs (NASDAQ:DOX) Releases Earnings Results, Beats Estimates By $0.01 EPS

Amdocs (NASDAQ:DOX) posted its quarterly earnings data on Wednesday. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01, FiscalAI reports. Amdocs had a net margin of 11.81% and a return on equity of 19.67%. The company had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the prior year, the business posted $1.78 EPS. The company’s quarterly revenue was up 3.9% on a year-over-year basis. Amdocs updated its FY 2026 guidance to 7.340-7.480 EPS and its Q3 2026 guidance to 1.810-1.870 EPS.

Here are the key takeaways from Amdocs’ conference call:

• Amdocs reported a solid Q2 revenue of $1.17 billion and non-GAAP EPS of $1.78, both above the midpoint of guidance, with year-over-year growth in North America and record revenue in Europe.
• The company secured several meaningful contract wins and extensions, including expanded managed services with Cricket Wireless, a 5-year CRM/OSS modernization deal with Vodafone Spain, and a multi-year charging system extension with KT.
• Amdocs said its new aOS agentic operating system is getting early traction, with initial commercial agreements from Cricket, Lumen, Bell Canada, EchoStar, and PLDT; PLDT is already seeing over 90% of customer requests resolved through the platform.
• Management reiterated full-year fiscal 2026 guidance, including 3% constant-currency revenue growth at the midpoint and roughly 6% non-GAAP EPS growth, while noting it is still monitoring customer spending amid macro uncertainty.
• Cash generation remained strong, with $97 million in free cash flow before restructuring in Q2 and the company on track for $710 million to $730 million for fiscal 2026, supporting continued shareholder returns and liquidity.

Amdocs Stock Up 3.3%

Shares of DOX stock opened at $61.93 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The firm’s 50-day moving average is $65.41 and its 200-day moving average is $73.65. The stock has a market cap of $6.69 billion, a price-to-earnings ratio of 12.39, a PEG ratio of 1.06 and a beta of 0.40. Amdocs has a 52-week low of $59.40 and a 52-week high of $95.41.

Amdocs Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date of this dividend is Tuesday, June 30th. Amdocs’s dividend payout ratio is presently 44.10%.

Institutional Investors Weigh In On Amdocs

Institutional investors and hedge funds have recently modified their holdings of the company. Intech Investment Management LLC bought a new stake in shares of Amdocs in the 3rd quarter valued at about $414,000. Scotia Capital Inc. raised its holdings in shares of Amdocs by 3.5% in the 3rd quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock valued at $352,000 after purchasing an additional 145 shares during the period. Inspire Investing LLC raised its holdings in Amdocs by 7.5% in the 4th quarter. Inspire Investing LLC now owns 4,058 shares of the technology company’s stock valued at $327,000 after acquiring an additional 284 shares during the period. Fred Alger Management LLC bought a new position in Amdocs in the 4th quarter valued at about $320,000. Finally, Aristides Capital LLC raised its holdings in Amdocs by 43.6% in the 3rd quarter. Aristides Capital LLC now owns 3,173 shares of the technology company’s stock valued at $260,000 after acquiring an additional 963 shares during the period. 92.02% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently commented on DOX. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, April 18th. Weiss Ratings restated a “hold (c-)” rating on shares of Amdocs in a research note on Friday, May 8th. Barclays reduced their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Cfra downgraded shares of Amdocs to a “sell” rating in a research note on Thursday. Finally, Stifel Nicolaus reduced their price objective on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research note on Thursday. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $86.67.

Amdocs News Roundup

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs reported Q2 revenue of $1.17 billion, up 3.9% year over year, and non-GAAP EPS of $1.78, slightly ahead of estimates. Management also raised confidence in the business with fiscal 2026 revenue growth expectations and reiterated strong free cash flow guidance. Article Title
• Positive Sentiment: The company said twelve-month backlog rose to $4.28 billion, suggesting continued demand visibility and supporting expectations for steady medium-term revenue. Article Title
• Positive Sentiment: Amdocs continues to win and expand customer relationships, including a new multi-year agreement with Telefónica Móviles Argentina, a cloud migration effort with Lumen Technologies, and Vodafone Ireland’s go-live on Amdocs network inventory tools. These wins point to ongoing enterprise traction. Article Title
• Positive Sentiment: The company also highlighted AI momentum, including availability of Telco Agents in Google’s Gemini Enterprise Agent Marketplace and a new performance benchmark for its Entitlement Server on Microsoft Azure, reinforcing the investment case around its GenAI pivot. Article Title
• Neutral Sentiment: Amdocs announced its third-quarter 2026 investor conference schedule, which is routine investor-relations activity and not a major operating update. Article Title
• Negative Sentiment: The company’s GAAP operating margin narrowed due to leadership-transition costs, and its shares remain well below the 50-day and 200-day moving averages, suggesting the stock is still working through a longer-term downtrend despite the recent positive results.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.